Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Structure Therapeutics In...

    NASDAQ: GPCR · Real-Time Price · USD
    20.79
    -0.29 (-1.38%)
    At close: Jun 30, 2025, 3:59 PM
    20.74
    -0.22%
    After-hours: Jun 30, 2025, 04:22 PM EDT

    Structure Therapeutics Statistics

    Share Statistics

    Structure Therapeutics has 57.54M shares outstanding. The number of shares has increased by 0.42% in one year.

    Shares Outstanding

    n/a
    		 57.54M

    Shares Change (YoY)

    n/a
    		 0.42%

    Shares Change (QoQ)

    n/a
    		 0.06%

    Owned by Institutions (%)

    n/a
    		 38.37%

    Shares Floating

    n/a
    		 54.69M

    Failed to Deliver (FTD) Shares

    n/a
    		 200

    FTD / Avg. Volume

    n/a
    		 0.02%

    Short Selling Information

    The latest short interest is 8.27M, so 14.38% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 8.27M

    Short % of Shares Out

    n/a
    		 14.38%

    Short % of Float

    n/a
    		 20.76%

    Short Ratio (days to cover)

    n/a
    		 9.17

    Valuation Ratios

    The PE ratio is -11.65 and the forward PE ratio is -14.16. Structure Therapeutics's PEG ratio is 2.61.

    PE Ratio

    n/a
    		 -11.65

    Forward PE

    n/a
    		 -14.16

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 1.7

    PB Ratio

    n/a
    		 1.65

    P/FCF Ratio

    n/a
    		 -12.11

    PEG Ratio

    n/a
    		 2.61
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Structure Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 24.74, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 24.74

    Quick Ratio

    n/a
    		 24.74

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.03

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-751,693.25

    Employee Count

    n/a
    		 163

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 310K

    Effective Tax Rate

    n/a
    		 -0.25%

    Stock Price Statistics

    The stock price has increased by -46.24% in the last 52 weeks. The beta is -1.97, so Structure Therapeutics's price volatility has been lower than the market average.

    Beta

    n/a
    		 -1.97

    52-Week Price Change

    n/a
    		 -46.24%

    50-Day Moving Average

    n/a
    		 23.32

    200-Day Moving Average

    n/a
    		 28.46

    Relative Strength Index (RSI)

    n/a
    		 42.73

    Average Volume (20 Days)

    n/a
    		 984,566

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -158.23M

    Net Income

    n/a
    		 -122.53M

    EBITDA

    n/a
    		 -158.23M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -2.33
    Full Income Statement

    Balance Sheet

    The company has 169.51M in cash and 3.86M in debt, giving a net cash position of 165.65M.

    Cash & Cash Equivalents

    n/a
    		 169.51M

    Total Debt

    n/a
    		 3.86M

    Net Cash

    n/a
    		 165.65M

    Retained Earnings

    n/a
    		 -329.1M

    Total Assets

    n/a
    		 866.55M

    Working Capital

    n/a
    		 813.13M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -116.64M and capital expenditures -1.29M, giving a free cash flow of -117.93M.

    Operating Cash Flow

    n/a
    		 -116.64M

    Capital Expenditures

    n/a
    		 -1.29M

    Free Cash Flow

    n/a
    		 -117.93M

    FCF Per Share

    n/a
    		 -0.75
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    GPCR does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for GPCR is $75, which is 255.3% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $75

    Price Target Difference

    n/a
    		 255.3%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 8
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 5.86

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist